| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/15/2009 | EP1437140B1 Oral pharmaceutical formulation containing active carbon and use of the same |
| 04/15/2009 | EP1390490B1 Muscle-specific expression vectors |
| 04/15/2009 | EP1373506B1 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter |
| 04/15/2009 | EP1311532B1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 04/15/2009 | EP1161452B1 Covalently bridged insulin dimers |
| 04/15/2009 | EP1012267B1 An antisense oligonucleotide preparation method |
| 04/15/2009 | CN101410397A Organic compounds |
| 04/15/2009 | CN101410392A Amide substituted quinolines |
| 04/15/2009 | CN101410384A Compounds and methods for modulating protein trafficking |
| 04/15/2009 | CN101410362A Lipid derivatives |
| 04/15/2009 | CN101410134A Filamentous bacteriophage displaying protein as a binder of antibodies and immunocomplexes for delivery to the brain |
| 04/15/2009 | CN101410131A Lipid-metabolism-improving agent |
| 04/15/2009 | CN101410128A Use of probiotic microorganisms for the treatment and prevention of obesity and related disorders |
| 04/15/2009 | CN101410110A Varenicline standards and impurity controls |
| 04/15/2009 | CN101410107A MIF inhibitors |
| 04/15/2009 | CN101410102A Compositions and methods for enhancing the antioxidant status of animals |
| 04/15/2009 | CN101410101A Anti-fat-accumulation composition |
| 04/15/2009 | CN101407796A Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 04/15/2009 | CN101407558A Preparation of Dendrobium nobile polysaccharide extract and use there |
| 04/15/2009 | CN101407557A Preparation and use of Dendrobium nobile polysaccharide extract |
| 04/15/2009 | CN101407531A Use of dimer hydrolysable tannins derivative in preparing medicament and diet additive for treating obesity |
| 04/15/2009 | CN101406666A Chinese medicine for treating coronary heart disease and angina pectoris, and preparation method and use thereof |
| 04/15/2009 | CN101406647A Health-care tea having fat-reducing effect |
| 04/15/2009 | CN101406644A Medicament with function for reducing blood sugar |
| 04/15/2009 | CN101406642A Antihypelipidemic compound formulation |
| 04/15/2009 | CN101406627A Chinese medicine powder for treating diabetic |
| 04/15/2009 | CN101406619A Hypoglycemic capsules containing astragalus and leech, and preparation method thereof |
| 04/15/2009 | CN101406618A Composition containing ginseng, astragalus, tuckahoe and largehead atractylodes rhizome |
| 04/15/2009 | CN101406616A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
| 04/15/2009 | CN101406615A Pharmaceutical combination for preventing birth-defect and improving memory |
| 04/15/2009 | CN101406614A Pharmaceutical combination for preventing birth-defect and improving memory |
| 04/15/2009 | CN101406602A Hypoglycemic capsules containing seven ingredients with rehmannia |
| 04/15/2009 | CN101406598A Chinese medicine composite for treating diabetes and preparation method thereof |
| 04/15/2009 | CN101406576A Chinese medicine for treating diabetes and preparation method |
| 04/15/2009 | CN101406571A Medicament with health-care function |
| 04/15/2009 | CN101406562A Decoction for treating diabetes and preparation method |
| 04/15/2009 | CN101406550A Composite plant preparation with auxiliary fat-reducing efficacy |
| 04/15/2009 | CN101406549A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
| 04/15/2009 | CN101406541A Four-flavor haw thorn granule |
| 04/15/2009 | CN101406537A Use of Geum japonicum Thunb. var. Chinense F. Bolle extract for preparing medicament for treating fat |
| 04/15/2009 | CN101406528A Composite of Chinese traditional medicine for diabetes mellitus |
| 04/15/2009 | CN101406519A Method for extracting plant extract for preventing and treating diabetes as well as extract product and uses thereof |
| 04/15/2009 | CN101406507A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence |
| 04/15/2009 | CN101406506A Pharmaceutical combination for preventing birth-defect and improving memory |
| 04/15/2009 | CN101406505A Pharmaceutical combination for preventing birth-defect and improving memory |
| 04/15/2009 | CN101406498A Effective hypoglycemic component of may flower and preparation method and use thereof |
| 04/15/2009 | CN101406492A Compound Cordyceps sinensis oil soft capsule and preparation technique |
| 04/15/2009 | CN101406479A Double-melon antihypelipidemic composition |
| 04/15/2009 | CN101406465A Combination of a serotonin reuptake inhibitor and a 5-HT2C antagonist, inverse agonist or partial agonist |
| 04/15/2009 | CN101406294A Dietary fiber and method of preparing dispersible tablet |
| 04/15/2009 | CN101406232A Fat-eliminating antihypelipidemic health tea |
| 04/15/2009 | CN100478351C Extractive of alfalfa, preparation method and usage |
| 04/15/2009 | CN100478343C Purine compound and use as cannabinoid receptor ligands |
| 04/15/2009 | CN100478340C Pyrrole-2, 5-dithione derivatives as liver X receptor modulators |
| 04/15/2009 | CN100478032C Preparation method of injection type pH and glucose sensitive hydrogel |
| 04/15/2009 | CN100478029C Immunomodulatory human MHC class II antigen-binding polypeptides |
| 04/15/2009 | CN100478022C Synergistic composition for treating hyperlipemia |
| 04/14/2009 | US7517989 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/14/2009 | US7517987 Interleukin converting enzyme inhibitors such as 5-Fluoro-4-oxo-3-(2-(6-oxo-6H-pyrimidin-1-yl)-butyrylamino)-pentanoic acid, administered as modulators of cell apoptosis and inflammation |
| 04/14/2009 | US7517910 Alkoxyphenylpropanoic acid derivatives |
| 04/14/2009 | US7517909 Using 3-amino-5-methyl-octanoic acid for therapy of psychiatric, pain and other disorders |
| 04/14/2009 | US7517907 specific activator of retinoic acid receptors subtype beta; 6-[3-adamantan-1-yl-4-(2,2-dimethyl[1,3]dioxoian-4-ylmethoxy)phenyl]naphthalene-2-carboxylic acid; useful in human or veterinary medicine; for body/hair hygiene, treating acne-prone skin, promoting hair regrowth, limiting hair loss, dry skin |
| 04/14/2009 | US7517892 Ligands for monoamine receptors and transporters, and methods of use thereof |
| 04/14/2009 | US7517661 Methods of screening for ligands for FPRL2 |
| 04/14/2009 | US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases |
| 04/14/2009 | US7517646 Provides functional molecule having an affinity and specificity to a target comparable to the affinity and specificity of an antibody against an antigen; modified oligonucleotide sequence |
| 04/14/2009 | US7517529 Using gene-regulatory peptide |
| 04/14/2009 | US7517525 Methods of inhibiting amyloid toxicity |
| 04/14/2009 | US7517517 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2387532C Suppressor of anemia and appetite suppressor |
| 04/14/2009 | CA2355341C The use of ara as a supplement for a lactating woman |
| 04/14/2009 | CA2329004C Combination of insulin sensitizer with anorectic for treating or preventing diabetes |
| 04/09/2009 | WO2009046371A1 Methods of treating metabolic diseases |
| 04/09/2009 | WO2009046220A2 Lipopeptides for delivery of nucleic acids |
| 04/09/2009 | WO2009046015A2 Combination therapies for treating type 1 diabetes |
| 04/09/2009 | WO2009045831A1 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof |
| 04/09/2009 | WO2009045830A1 Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof |
| 04/09/2009 | WO2009045753A1 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors |
| 04/09/2009 | WO2009045520A2 Water-dispersible phytosterol-surfactant conglomerate particles |
| 04/09/2009 | WO2009045476A1 Pyrimidinedione derivatives |
| 04/09/2009 | WO2009045313A2 Oxypiperidine derivatives as histamine receptor antagonists |
| 04/09/2009 | WO2009045291A2 Mast cell stabilizers in the treatment of obesity |
| 04/09/2009 | WO2009045122A1 Medicinal agent for treating and preventing diabetes complications |
| 04/09/2009 | WO2009045101A1 Use of diazoxide for suppressing the plasma insulin level in a mammal |
| 04/09/2009 | WO2009044930A1 Pharmaceutical composition for inhibiting the accumulation of amyloid-β protein |
| 04/09/2009 | WO2009044918A1 Neuromedin u derivative |
| 04/09/2009 | WO2009044788A1 Benzoxazinone derivative |
| 04/09/2009 | WO2009044555A1 Preparation and method of administering vaccine and iontophoresis device using the preparation |
| 04/09/2009 | WO2009044554A1 Preparation and method of administering vaccine and iontophoresis device using the preparation |
| 04/09/2009 | WO2009044160A1 Pyridine derivatives for the treatment of amyloid-related diseases |
| 04/09/2009 | WO2009043879A1 Composition for controlling lipase catalyzed reactions |
| 04/09/2009 | WO2009043834A1 Pharmaceutical compositions of 5-hydr0xytrypt0phan and serotonin-enhancing compound |
| 04/09/2009 | WO2009043529A1 Thyrotropin releasing hormone for therapeutic applications |
| 04/09/2009 | WO2009043528A1 Substance p and thyrotropin releasing hormone for therapeutic applications |
| 04/09/2009 | WO2009043527A2 Therapeutic use of human growth hormone 1-43 |
| 04/09/2009 | WO2009043526A2 Use of gip ( 6-30) alone or in combination with hgh as a therapeutic agent |
| 04/09/2009 | WO2009043524A2 Use of a peptide as therapeutic agent |
| 04/09/2009 | WO2009043523A2 Cortistatin 17 and neuropeptide 1 for use as therapeutic agent |
| 04/09/2009 | WO2009043522A2 Use of a peptide as a therapeutic agent |